Lifesciences Equipment Leasing Market in US 2024-2028

Description

List of Tables

The lifesciences equipment leasing market in US is forecasted to grow by USD 685.99 mn during 2023-2028, accelerating at a CAGR of 7.7% during the forecast period. The report on the lifesciences equipment leasing market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high cost of life sciences equipment, growing demand from low-budget research institutions, and continuous technological advancements coupled with shorter lifecycles.

Technavio's lifesciences equipment leasing market in US is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	6.63%
CAGR	7.7%
Incremental Value	$685.99mn

By End-user

Pharmaceutical companies
Biopharmaceutical companies

By Product

Chromatography systems
Centrifuges
Mass spectrometry
Incubators
Microscope and others

By Type

Capital lease
Operating lease
Hire purchase

This study identifies the uberization of life sciences equipment leasing as one of the prime reasons driving the lifesciences equipment leasing market in US growth during the next few years. Also, integration of digital platforms by life sciences equipment lessors and rising demand for full leasing of life sciences equipment will lead to sizable demand in the market.

The report on the lifesciences equipment leasing market in US covers the following areas:

Lifesciences equipment leasing market in US sizing
Lifesciences equipment leasing market in US forecast
Lifesciences equipment leasing market in US industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading lifesciences equipment leasing market in US vendors that include Agilent Technologies Inc., American Capital Group Inc., Avtech Financial Group of companies, Commercial Finance and Leasing Cardiff Bank Inc., Crestmont Capital LLC, CSC Leasing Co., Danaher Corp., Excedr Inc., GeNESIS Commercial Capital, GenTech Scientific LLC, Olympus Corp., Peoples Bancorp Inc., Rabobank Group, Royal Bank of Canada, Scientific Equipment Source Inc., Siemens AG, STINSON LLP, Sun South Equipment Leasing Inc., Thermo Fisher Scientific Inc., and Waters Corp.. Also, the lifesciences equipment leasing market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR77768

1 Executive Summary

1.1 Market overview

2 Market Landscape

2.1 Market ecosystem

3 Market Sizing

3.1 Market definition
3.2 Market segment analysis
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

4.1 Lifesciences equipment leasing market in US 2018 - 2022
4.2 End-user Segment Analysis 2018 - 2022
4.3 Product Segment Analysis 2018 - 2022
4.4 Type Segment Analysis 2018 - 2022

5 Five Forces Analysis

5.1 Five forces summary
5.2 Bargaining power of buyers
5.3 Bargaining power of suppliers
5.4 Threat of new entrants
5.5 Threat of substitutes
5.6 Threat of rivalry
5.7 Market condition

6 Market Segmentation by End-user

6.1 Market segments
6.2 Comparison by End-user
6.3 Pharmaceutical companies - Market size and forecast 2023-2028
6.4 Biopharmaceutical companies - Market size and forecast 2023-2028
6.5 Market opportunity by End-user

7 Market Segmentation by Product

7.1 Market segments
7.2 Comparison by Product
7.3 Chromatography systems - Market size and forecast 2023-2028
7.4 Centrifuges - Market size and forecast 2023-2028
7.5 Mass spectrometry - Market size and forecast 2023-2028
7.6 Incubators - Market size and forecast 2023-2028
7.7 Microscope and others - Market size and forecast 2023-2028
7.8 Market opportunity by Product

8 Market Segmentation by Type

8.1 Market segments
8.2 Comparison by Type
8.3 Capital lease - Market size and forecast 2023-2028
8.4 Operating lease - Market size and forecast 2023-2028
8.5 Hire purchase - Market size and forecast 2023-2028
8.6 Market opportunity by Type

9 Customer Landscape

9.1 Customer landscape overview

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
11.3 Landscape disruption
11.4 Industry risks

12 Vendor Analysis

12.1 Vendors covered
12.2 Market positioning of vendors
12.3 Agilent Technologies Inc.
12.4 American Capital Group Inc.
12.5 Avtech Financial Group of companies
12.6 Commercial Finance and Leasing Cardiff Bank Inc.
12.7 CSC Leasing Co.
12.8 Danaher Corp.
12.9 Excedr Inc.
12.10 Olympus Corp.
12.11 Rabobank Group
12.12 Royal Bank of Canada
12.13 Scientific Equipment Source Inc.
12.14 Siemens AG
12.15 STINSON LLP
12.16 Thermo Fisher Scientific Inc.
12.17 Waters Corp.

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
13.3 Currency conversion rates for US$
13.4 Research methodology
13.5 List of abbreviations